Italy· 027218015
RITMODAN RETARD*20 cpr 250 mg
A medicinal product containing disopiramide, registered in Italy by CHEPLAPHARM ARZNEIMITTEL GMBH, on the national reimbursement list.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Active substance
- Disopiramide
- Manufacturer
- CHEPLAPHARM ARZNEIMITTEL GMBH
- Country
- Italy (IT)
- ATC code
- —
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic027218015RITMODAN RETARD*20 cpr 250 mgEUR 6.94
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Disopiramide in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDirythmin SA 150mg tabletsAstraZeneca UK Ltd
- United StatesDisopyramide PhosphateMylan Pharmaceuticals Inc.
- FranceISORYTHM L.P. 125 mg, gélule à libération prolongéeSERP
- NorwayRitmodan RetardSanofi
- FinlandDurbissanofi-Aventis Oy
- BelgiumRythmodan 100 mgCheplapharm Arzneimittel
- CanadaRYTHMODANCHEPLAPHARM ARZNEIMITTEL GMBH
- SpainDICORYNAN 100 mg CAPSULAS DURASCheplapharm Arzneimittel Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Belgium · Rythmodan, Rythmodan Long Action
- Spain · Dicorynan
- France · Isorythm L.P., Rythmodan
- United Kingdom (Northern Ireland) · Disopyramide Neon, Disopyramide Neon Healthcare
- Luxembourg · Rythmodan, Rythmodan Long Action
- Netherlands · Ritmoforine Retard
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7172e0dc-239c-4cc9-825c-3e7eac6613fa GET /v1/drugs/7172e0dc-239c-4cc9-825c-3e7eac6613fa?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 6.94,
"source": "aifa",
"currency": "EUR",
"strength": "DISOPIRAMIDE 250MG 20 UNITA' USO ORALE",
"substance": "Disopiramide",
"equivalence_group": "KJB",
"transparency_flag": null
}See everything about disopiramide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.